Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine
Open Access
- 22 November 2018
- journal article
- research article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 39 (12) , 2237-2242
Abstract
BACKGROUND AND PURPOSE: The assessment of brain atrophy in a clinical routine is not performed routinely in multiple sclerosis. Our aim was to determine the feasibility of brain atrophy measurement and its association with disability progression in patients with MS followed in a clinical routine for 5 years. MATERIALS AND METHODS: A total of 1815 subjects, 1514 with MS and 137 with clinically isolated syndrome and 164 healthy individuals, were collected retrospectively. Of 11,794 MR imaging brain scans included in the analysis, 8423 MRIs were performed on a 3T, and 3371 MRIs, on a 1.5T scanner. All patients underwent 3D T1WI and T2-FLAIR examinations at all time points of the study. Whole-brain volume changes were measured by percentage brain volume change/normalized brain volume change using SIENA/SIENAX on 3D T1WI and percentage lateral ventricle volume change using NeuroSTREAM on T2-FLAIR. RESULTS: Percentage brain volume change failed in 36.7% of the subjects; percentage normalized brain volume change, in 19.2%; and percentage lateral ventricle volume change, in 3.3% because of protocol changes, poor scan quality, artifacts, and anatomic variations. Annualized brain volume changes were significantly different between those with MS and healthy individuals for percentage brain volume change (P < .001), percentage normalized brain volume change (P = .002), and percentage lateral ventricle volume change (P = .01). In patients with MS, mixed-effects model analysis showed that disability progression was associated with a 21.9% annualized decrease in percentage brain volume change (P < .001) and normalized brain volume (P = .002) and a 33% increase in lateral ventricle volume (P = .004). CONCLUSIONS: All brain volume measures differentiated MS and healthy individuals and were associated with disability progression, but the lateral ventricle volume assessment was the most feasible.Keywords
This publication has 30 references indexed in Scilit:
- Clinical Relevance of Brain Volume Measures in Multiple SclerosisCNS Drugs, 2014
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisAnnals of Neurology, 2013
- Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple SclerosisRadiology, 2013
- The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosisHuman Brain Mapping, 2011
- Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypesNeurology, 2010
- Gradient distortions in MRI: Characterizing and correcting for their effects on SIENA-generated measures of brain volume changeNeuroImage, 2010
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisNeurology, 2008
- The measurement and clinical relevance of brain atrophy in multiple sclerosisThe Lancet Neurology, 2006
- Longitudinal Brain Volume Measurement in Multiple SclerosisArchives of Neurology, 2002
- Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2002